FDA Panel Rejects Prostate Cancer Prevention Drug
Links shared publicly online about this topic
FDA Panel Rejects Two Drugs for Prostate Cancer Prevention - AOL Health
aolhealth.com — “A panel of federal health on Wednesday rejected the use of two drugs from Merck and GlaxoSmithKline to prevent prostate cancer, saying the drugs could” View full resource at aolhealth.com
Most Recently Shared on December 3, 2010 at 6:45 pm By:
FDA rejects two drugs for prostate cancer prevention. http://aol.it/gxm8Zg #prostate #cancer
FDA Panel Rejects Use of BPH Drugs for Prostate Cancer Prevention - Renal and Urology News
renalandurologynews.com — “An FDA advisory panel has voted against expanding the labeling of dutasteride (Avodart, GlaxoSmithKline) and finasteride (Proscar, Merck) so that these drugs--"which are indicated for the treatment of benign prostatic hyperplasia (BPH)--"could be marketed for the prevention of prostate cancer (PCa) in men at risk for the disease.” View full resource at renalandurologynews.com
Most Recently Shared on December 3, 2010 at 1:31 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
FDA Panel Rejects Use of BPH Drugs for Prostate Cancer Prevention: An FDA advisory panel has voted against expan... http://bit.ly/dNQ4zo
Medical News: FDA Panel Rejects Prostate Drugs for CA Prevention - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “SILVER SPRING, Md. -- An FDA advisory panel has voted overwhelmingly that GlaxoSmithKline's dutasteride (Avodart) and Merck's finasteride (Proscar) should not be used to prevent prostate cancer becaus” View full resource at medpagetoday.com
Most Recently Shared on December 2, 2010 at 12:37 am By:
FDA Panel Rejects Prostate Drugs for CA Prevention http://bit.ly/fgyEA8
FDA Panel Votes Against Drugs Said to Prevent Prostate Cancer
everydayhealth.com — “Experts were concerned about rare risk of aggressive tumors in patients using the meds” View full resource at everydayhealth.com
Most Recently Shared on December 3, 2010 at 12:00 am By:
FDA panel votes against drugs said to prevent #prostatecancer http://ow.ly/3iPko
FDA Panel to Vote on Drugs to Prevent Prostate Cancer - Drugs.com MedNews
drugs.com — “A U.S. Food and Drug Administration advisory panel is expected to decide Wednesday whether to approve two drugs for the prevention of prostate cancer, the third” View full resource at drugs.com
Most Recently Shared on December 1, 2010 at 9:56 pm By:
FDA Panel to Vote on Drugs to Prevent Prostate Cancer - http://bit.ly/ebKWGl
FDA Panel Votes Against Drugs Said to Prevent Prostate Cancer - MSN Health - Cancer
health.msn.com — “Experts were concerned about rare risk of aggressive tumors in patients using the meds” View full resource at health.msn.com
Most Recently Shared on December 1, 2010 at 5:46 pm By:
FDA Panel to Vote on Drugs to Prevent Prostate Cancer: http://on-msn.com/eK285Y
Panel Opposes Avodart, Proscar to Prevent Prostate Cancer - WSJ.com
online.wsj.com — “A panel said drugs used to treat enlarged prostates in men shouldn't be used to prevent prostate cancer.” View full resource at online.wsj.com
Most Recently Shared on December 1, 2010 at 11:17 pm By:
Panel Opposes Avodart, Proscar to Prevent Prostate Cancer http://bit.ly/hPKLpt
Avodart Gets Rejected By FDA For Reducing Prostate Cancer Risk : Shots - Health News Blog : NPR
npr.org — “The Food and Drug Administration is not willing to expand the approval of an existing drug for enlarged prostates as a means to reduce the risk of prostate cancer. A panel of expert previously recommended against the expansion.” View full resource at npr.org
Most Recently Shared on January 27, 2011 at 7:38 pm By:
Avodart Gets Rejected By FDA For Reducing Prostate Cancer Risk http://bit.ly/fvOCNL
Avodart Gets Rejected By FDA For Reducing Prostate Cancer Risk : Shots - Health News Blog : NPR
npr.org — “The Food and Drug Administration is not willing to expand the approval of an existing drug for enlarged prostates as a means to reduce the risk of prostate cancer. A panel of expert previously recommended against the expansion.” View full resource at npr.org
Most Recently Shared on January 27, 2011 at 7:49 pm By:
Avodart Gets Rejected By FDA For Reducing Prostate Cancer Risk http://n.pr/gsYOfu
FDA panel votes against wider use of Amgen drug | Reuters
reuters.com — “WASHINGTON (Reuters) - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance” View full resource at reuters.com
Most Recently Shared on February 9, 2012 at 4:05 am By:
FDA panel votes against wider use of Amgen drug: WASHINGTON (Reuters) - An advisory panel on Wednesday recommend... http://t.co/W9qkRVJr
F.D.A. Panel Won--™t Expand Use of Prostate Drug - NYTimes.com
nytimes.com — “If the drug advisory panel had supported the changing of two drugs--™ labels, dutasteride and finasteride would be only the second class of cancer-prevention drugs on the market.” View full resource at nytimes.com
Most Recently Shared on December 2, 2010 at 5:02 pm By:
Gina Kolata Health Communicator
Do men want a drug to reduce the risk of prostate cancer?http://www.nytimes.com/2010/12/02/health/policy/02drug.html?_r=1&hpw
ODAC rejects expanded use for bone drug in men with prostate cancer | HemOncToday
hemonctoday.com — “The FDA’s Oncologic Drugs Advisory Committee rejected a request from Amgen to allow denosumab to be used as a preventive measure for men w” View full resource at hemonctoday.com
Most Recently Shared on February 9, 2012 at 1:11 pm By:
HemOnc Today Oncology and Health News
ODAC rejects expanded use for bone drug in men with prostate cancer: http://t.co/eFDclp28
A.M. Vitals: FDA Advisory Panel Votes Against Drugs as Prostate-Cancer Preventatives - Health Blog - WSJ
blogs.wsj.com — “Also: food-safety bill hits a snag; Allergan seeks broader (though thinner) audience for Lap-Band; PhRMA dollars; Merck bets on experimental insulin product.” View full resource at blogs.wsj.com
Most Recently Shared on December 2, 2010 at 2:16 pm By:
A.M. Vitals: FDA Advisory Panel Votes Against Drugs as Prostate-Cancer Preventatives http://bit.ly/eySPnj
FDA Panel Reviews BPH Drugs for Reducing Prostate Cancer Risk : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on December 2, 2010 at 1:32 am By:
Bob Finn - Medical News Net Health News
FDA panel doesn't like risk/benefit ratio of finasteride & dutasteride for prostate ca prevention. @elizmech reports. http://bit.ly/hB5rtH
F.D.A. Panel Won--™t Expand Use of Prostate Drug - NYTimes.com
nytimes.com — “If the drug advisory panel had supported the changing of two drugs--™ labels, dutasteride and finasteride would be only the second class of cancer-prevention drugs on the market.” View full resource at nytimes.com
Most Recently Shared on December 2, 2010 at 3:47 am By:
F.D.A. Panel Rejects Expanded Use of Prostate Drug http://nyti.ms/dW8kbd
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
HealthPop
Write about health, diet, fitness, relationships. Our blog is @Thats_Fit.
-
Renal Urology News
Renal and Urology News reports on clinical news for both nephrologists and urologists.
-
Medical News
unbiased curator, editor & aggregator of the latest medical and healthcare news and information
Advertisement
